Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF).

Arata AzumaArata AzumaVincent CottinMichael KreuterToby M MaherFernando J MartinezJustin M OldhamClaudia ValenzuelaMaud GordatYi LiuSusanne StowasserDonald F ZozMarlies S Wijsenbeek

Published in: BMJ open respiratory research (2023)

NCT05321069.

Keyphrases

idiopathic pulmonary fibrosis
double blind
phase iii
placebo controlled
clinical trial
phase ii
interstitial lung disease
study protocol
open label
randomized controlled trial
rheumatoid arthritis